cs.CVFeb 14, 2026

MamaDino: A Hybrid Vision Model for Breast Cancer 3-Year Risk Prediction

Authors: Ruggiero Santeramo, Igor Zubarev, Florian Jug

Organizations: Fondazione Human Technopole, Milan, Italy

Abstract

Breast cancer screening programmes increasingly seek to move from one-size-fits-all intervals to risk-adapted and personalized strategies. Deep learning (DL) has enabled image-based risk models with stronger 1- to 5-year prediction than clinical models, but leading systems (e.g., Mirai) typically use convolutional backbones, high-resolution inputs (>1M pixels) and simple multi-view fusion, with limited explicit modelling of contralateral asymmetry. We hypothesised that combining complementary inductive biases (convolutional and transformer-based) with explicit contralateral asymmetry modelling would allow us to match state-of-the-art 3-year risk prediction performance on lower-resolution mammograms, suggesting that using less detail in a more structured way can recover state-of-the-art accuracy. We present MamaDino, a mammography-aware multi-view attentional DINO model. MamaDino fuses frozen self-supervised DINOv3 ViT-S features with a trainable CNN encoder at 512x512 resolution and aggregates bilateral breast information via a BilateralMixer to output a 3-year breast cancer risk score. We train on 53,883 women from OPTIMAM (UK) and evaluate on matched 3-year case-control cohorts: an in-distribution test set from four screening sites and an external out-of-distribution cohort from an unseen site. At breast level, MamaDino achieves discrimination comparable to Mirai on internal and external tests while using ~13x fewer input pixels. Adding the BilateralMixer improves patient-level discrimination to AUC 0.736 (vs Mirai 0.713) in-distribution and 0.677 (vs Mirai 0.676) out-of-distribution, with overlapping confidence intervals. Performance was evaluated across age, ethnicity, scanner manufacturer, tumour type and grade. These findings suggest that complementary inductive biases and explicit contralateral modelling can achieve Mirai-comparable discrimination at lower resolution.

Figures & tables

Appendix figures & tables3 assets

Supplementary material from the paper’s appendix.

Appendix

Explore similar work

Jul 13, 2026

Longitudinal Multi-View Breast Cancer Risk Prediction

Accurate breast cancer risk prediction from screening mammography is critical for enabling personalized screening intervals and early detection. Recent deep learning methods have shown the value of longitudinal data and explicit temporal alignment. However, existing approaches either perform explicit alignment using a single mammographic view or model multiple views without explicit longitudinal alignment, limiting their ability to exploit the complementary spatial-temporal information used in clinical practice. To address this gap, we propose LMV-Net, a longitudinal multi-view breast cancer risk prediction model that jointly analyzes anatomically complementary CC and MLO views within an explicitly aligned longitudinal framework. We evaluate our approach on the public EMBED and CSAW-CC datasets, comparing it to state-of-the-art breast cancer risk prediction methods. Our model consistently outperforms existing approaches in overall risk prediction performance and across different breast density and cancer subgroups. Importantly, these improvements highlight the potential of longitudinal multi-view modeling to enhance risk stratification, paving the way for future work on personalized screening, earlier identification of high-risk patients, and more efficient screening resource allocation. The code is available at https://github.com/sot176/LMV-Net.
Apr 13, 2026

LoGo-MR: Screening Breast MRI for Cancer Risk Prediction by Efficient Omni-Slice Modeling

Efficient and explainable breast cancer (BC) risk prediction is critical for large-scale population-based screening. Breast MRI provides functional information for personalized risk assessment. Yet effective modeling remains challenging as fully 3D CNNs capture volumetric context at high computational cost, whereas lightweight 2D CNNs fail to model inter-slice continuity. Importantly, breast MRI modeling for shor- and long-term BC risk stratification remains underexplored. In this study, we propose LoGo-MR, a 2.5D local-global structural modeling framework for five-year BC risk prediction. Aligned with clinical interpretation, our framework first employs neighbor-slice encoding to capture subtle local cues linked to short-term risk. It then integrates transformer-enhanced multiple-instance learning (MIL) to model distributed global patterns related to long-term risk and provide interpretable slice importance. We further apply this framework across axial, sagittal, and coronal planes as LoGo3-MR to capture complementary volumetric information. This multi-plane formulation enables voxel-level risk saliency mapping, which may assist radiologists in localizing risk-relevant regions during breast MRI interpretation. Evaluated on a large breast MRI screening cohort (~7.5K), our method outperforms 2D/3D baselines and existing SOTA MIL methods, achieving AUCs of 0.77-0.69 for 1- to 5-year prediction and improving C-index by ~6% over 3D CNNs. LoGo3-MR further improves overall performance with interpretable localization across three planes, and validation across seven backbones shows consistent gains. These results highlight the clinical potential of efficient MRI-based BC risk stratification for large-scale screening. Code will be released publicly.
Nov 15, 2026

Beyond AUC: Do Mammography Risk Models Predict When Cancer Occurs?

Longitudinal deep learning models for mammography-based breast cancer risk prediction output either per-year cumulative risks or a discrete distribution over the year of diagnosis, from which cumulative risks F1,...,F5 are derived. These models are evaluated almost exclusively with year-wise AUCs and the concordance index. We show that these metrics are largely insensitive to when cancer occurs: they can be high even for a model that carries no information about the year of diagnosis. We re-evaluate two recent longitudinal models (OA-BreaCR, LMV-Net) on CSAW-CC with a 5-year horizon using timing metrics computed on cancer cases only. Despite C-indices up to 0.75, neither orders cancer cases by time to diagnosis significantly better than chance (c_time 0.51 and 0.55, both 95% CIs covering 0.5). Weighted absolute timing error favours a constant "year 3" prediction over both models, so we use c_time as the primary timing metric. For Mirai's additive-hazard head, also used by LMV-Net, we analyse how per-year increments passed through a ReLU can collapse under severe class imbalance. We also propose a breast-level, two-stage model that separates whether from when. It matches LMV-Net in discrimination (C-index 0.745 vs. 0.746) but orders cancer cases better (c_time 0.58 vs. 0.51, paired 95% CI of the difference 0.01-0.13), on par with Mirai's published weights (0.57).